Fatty acid synthesis in the mammary gland of lactating rats in vivo was 5-fold higher than in the liver. Starvation decreased fatty acid synthesis in the gland 50-fold, whereas refeeding for 2h completely reversed this change. The plasma insulin concentration decreased 2-fold in starvation and was restored to the fed-rat value on refeeding. Glucagon and prolactin concentrations did not always change in parallel with lipogenesis, suggesting that insulin may be a regulator of this process in the gland.
The mammary gland makes a large demand on the total body glucose supplies (Williamson & Robinson, 1977) , and a major proportion of the glucose utilized in vitro is accounted for by fatty acid synthesis (Baldwin & Yang, 1974; Katz et al., 1974; Robinson & Williamson, 1977a,c) . Previous studies indicate that mammary-gland metabolism responds to altered hormonal and nutritional status of the lactating rat. Arteriovenous difference measurements across the gland showed that glucose uptake is decreased, whereas lactate and pyruvate are released in starvation (Hawkins & Williamson, 1972; Robinson & Williamson, 1977a) , and these changes may be related to the decreased activity of pyruvate dehydrogenase (Kankel & Reinauer, 1976; Baxter & Coore, 1978) . Recent studies with [U-14C] glucose have shown that the rate of lactose synthesis by the gland in vivo is decreased on short-term withdrawal of food (Carrick & Kuhn, 1977) . To obtain data for lipid synthesis we have measured the rate of lipogenesis in the gland in vivo with 3H20 (Jungas, 1968; Brunengraber et al., 1973; Stansbie et al., 1976) . In addition, the circulating concentrations of insulin, glucagon and prolactin have been measured to examine whether changes in their concentrations relate to alterations in the lipogenic rate.
Experimental
Lactating rats of the Wistar strain (250-300g) with between 6 and 14 pups were used after a lactation period of between 10 and 18 days. Virgin rats (200-300g) were used for comparison. Non-lactating rats refer to rats whose pups were removed at parturition and studied 13 to 15 days later. The rats were fed Vol. 176 ad libitum on Oxoid breeding diet (Oxoid Ltd., London S.E.1, U.K.). Starved rats (with pups) were deprived of food for 24h and starved-refed rats were allowed Oxoid pellets for 2h after 24h of starvation. Insulin and prolactin deficiency were induced as described by Robinson & Williamson (1977a) . 3H20 was obtained from The Radiochemical Centre, Amersham, Bucks., U.K.
Rates of lipogenesis were measured by intraperitoneal injection of 3H20 (5mCi in 0.5ml) into rats lightly anaesthetized with ether 30min before the end of the specified time of treatment. Rats were left with their litters for 30min, and litters were then removed. The rats were anaesthetized with Nembutal (50mg/kg body wt.; solution in 0.9 % NaCl) at about 50min after injection of 3H20, and at 60min duplicate samples of inguinal mammary gland, parametrial adipose tissue and liver were taken. Arterial blood was collected from the aorta into a heparinized tube for determination of specific radioactivity of plasma water. Weighed samples of the tissue (about 1 g in duplicate) and arterial blood (1 ml) were added to 3 ml of 30 % (w/v) KOH, and lipid was saponified and extracted by the method of Stansbie et al. (1976) .
Plasma insulin was measured by radioimmunoassay by using uncoated charcoal to separate bound and free hormone (Albano et al., 1972) . A purified rat insulin standard (24i.u./mg; Novo Research Institute, Copenhagen, Denmark) and an antiinsulin serum reacting poorly with proinsulin were used. Plasma glucagon was determined with a pancreatic-glucagon specific antibody K47 kindly supplied by L. G. Heding (Novo Research Institute) in an assay system described by Girard et al. (1972) . Plasma prolactin was determined with a kit from N.I.A.M.D. by using standard rat prolactin RP1 (11 i.u./mg) and anti-(rat prolactin) serum 4.
The following metabolites in neutralized HC104 extracts of blood were determined by enzymic methods: glucose (Slein, 1963) ; acetoacetate and D-3-hydroxybutyrate (Williamson etal., 1962) . Results and Discussion Lipogenesis in rat mammary gland was 5-fold greater than the rate in liver of lactating or virgin rats, and 25-fold greater than the rate in the gland of virgin rats (Table 1) . Lipogenic rates were similar in the liver of lactating rats and virgin rats fed glucose intragastrically immediately before injection of 3H20 (Table 1) , which is not consistent with the increased lipogenesis observed in liver in vitro during lactation (Smith, 1973a; Benito & Williamson, 1978) . Although lipogenesis was 36% lower in the liver of fed virgin rats not given glucose (results not shown), comparison with the virgin rats given glucose seems more valid in view of the high food consumption and continuous feeding of lactating rats. These lipogenic rates are similar to those reported in liver of male rats (Brunengraber et al., 1973; Stansbie et al., 1976; Cook et al., 1977) .
In starvation lipid synthesis in the mammary gland decreased 50-fold, and this dramatic change was completely reversed on refeeding for 2h (Table 1) . Lipogenesis in the liver of lactating rats decreased 10-fold in starvation and remained 50 % less than the rate in fed rats on refeeding. The increased lipogenesis found in the gland on refeeding was prevented by administration of streptozotocin immediately before refeeding, but not by bromocryptine injection 1 h before refeeding. Further evidence that the mammary gland may be particularly sensitive to shortterm regulation is the finding that streptozotocin treatment of fed rats decreased lipogenesis in the gland 7-fold, whereas the liver was not affected.
In parametrial adipose tissue of lactating and virgin rats lipogenesis was 3.4± 3.0 (n = 6) and 6.2± 3.8 (n = 6) ,umol of 3H20/h per g respectively. (Smith, 1973b) .
It is possible that a portion of the radioactivity in the gland may represent lipid synthesized in the liver and subsequently released into the circulation and taken up by the gland. However, this is unlikely to account for a large proportion of the 3H-labelled lipid found in the gland, since incorporation of 3H20 into blood lipid in fed lactating rats was not increased compared with virgin rats and paralleled changes in the lipogenic rate in the liver rather than the gland (Table 1) .
By using a gland weight and blood flow from the data of Chatwin et al. (1969) , lipid synthesis in the gland is 70mmol of 3H20/day compared with glucose utilization by the gland of 30mmol/day (Williamson & Robinson, 1977) . Thus it seems likely that glucose utilization by the gland in vivo is sufficient to account for the large demand made by lipogenesis in fed lactating rats. In starvation the decreased lipogenesis (Table 1) , in addition to the suppression of lactose synthesis (Carrick & Kuhn, 1977) , may decrease the glucose requirement of the gland, thus sparing body supplies.
In fed lactating rats plasma insulin concentrations were 60% lower than in virgin rats or non-lactating rats (Table 2) . After starvation (24h) insulin concentrations decreased by 50% in both groups and the 2.5-fold difference in concentration between lactating and virgin rats was maintained (Table 2) . Refeeding starved rats for 2h restored insulin concentrations to the value found for fed lactating rats. Plasma insulin concentrations were decreased to the starved value by streptozotocin treatment for 2h, but were not affected by bromocryptine treatment for 24h.
In other studies of lactating rats (Sutter-Dub et al., 1974; Kuhn, 1977) were about 2-fold higher than those in Table 2 , which may be due to differences in the radioimmunoassay techniques and site of blood sampling. Plasma insulin concentrations were higher in lactating rats than in non-lactating rats, whereas plasma glucose concentrations were about 6.Omm for both groups of rats in blood from the tail vein after starvation for 12h (Sutter-Dub et al., 1974) . This contrasts with the present studies where the lower plasma insulin concentrations in lactating rats compared with virgin rats are consistent with the lower blood glucose concentrations found in lactating rats (Table 2 ). In view of the increased food intake during lactation (Cole & Hart, 1938; Fell et al., 1963) it might be expected that plasma insulin concentrations would increase during lactation as in pregnancy (Saudek et al., 1975) , where the increased synthesis of insulin and enhanced secretory response to glucose by the pancreatic f8-cells has been related to the increased food intake (Green & Taylor, 1974; Bone & Howell, 1977) . A possible explanation is that removal and degradation of insulin by liver (Terris & Steiner, 1975) and mammary gland (Osborne et al., 1978) may be increased. Plasma glucagon concentrations in fed lactating rats were similar to those of non-lactating rats, but were 20 % lower than those ofvirgin rats (Table 2) . Since insulin concentrations were decreased in lactating rats compared with virgin rats, the ratio of [insulin]/[glucagon] was decreased 2-fold in lactating rats, suggesting that a catabolic state may prevail (Unger, 1971) . Glucagon concentrations tended to decrease in starvation and increase on refeeding or following streptozotocin treatment ( Table 2 ). The concentrations of glucagon found in these studies are similar to those reported previously (Saudek et al., 1975; De Jong et al., 1977) .
Prolactin concentrations were 2-fold higher in lactating rats compared with non-lactating rats and were not affected by starvation (Table 2 ). In previous studies (Amenomori et al., 1970; Simpson et al., 1973) somewhat lower prolactin concentrations were found. As was expected prolactin concentrations were decreased by bromocryptine treatment, but surprisingly streptozotocin also caused a decrease, although not to the same extent as bromocryptine (Table 2) .
Insulin is the only one of the three hormones whose concentrations altered in parallel with lipogenesis in all situations studied, which suggests that insulin may control this process in vivo. Some evidence that the decreased lipogenesis after streptozotocin treatment may be related to decreased insulin concentrations rather than the accompanying prolactin deficiency is the finding that bromocryptine treatment (3 h) did not abolish the effect of refeeding on lipogenesis in the gland (Table 1) Vol. 176 may control mammary-gland glucose metabolism in starvation (Williamson et al., 1975) . Ketone-body concentrations increase in starvation (Table 2) and there is evidence both in vivo (Robinson & Williamson, 1977b ) and in vitro (Williamson et al., 1975; Robinson & Williamson, 1977c ) that acetoacetate decreases glucose utilization in the gland. Insulin in vitro relieves the acetoacetate inhibition of glucose utilization and lipogenesis (Williamson et al., 1975; Robinson & Williamson, 1977c) , and the decreased insulin concentrations in starvation may potentiate inhibition of glucose utilization and lipogenesis by the increased blood acetoacetate concentrations.
Decreased lipogenesis in the gland in starvation may involve long-term changes in enzyme activities, as is the case in other lipogenic tissues (Volpe & Vagelos, 1976) , but the complete restoration of lipogenesis in the gland after 2h of refeeding suggests that the regulation is short term. Pyruvate dehydrogenase and acetyl-CoA carboxylase are possible regulatory steps in lipogenesis in the gland (Baldwin & Yang, 1974; Williamson & Robinson, 1977) . Pyruvate dehydrogenase activity shows parallel changes to lipogenesis in starvation (Kankel & Reinauer, 1976; Baxter & Coore, 1978) and after streptozotocin treatment (Field & Coore, 1976) . It is not known whether acetyl-CoA carboxylase in the gland undergoes changes in activity in starvation and on refeeding, and whether insulin has direct effects on its activity.
In conclusion, these studies have demonstrated the high lipogenic rate in the mammary gland and its extreme sensitivity to the nutritional state. Such tight regulation would be expected in view of the large demand normally made by the gland on body glucose supplies. Insulin may be of prime importance in regulation of lipogenesis and glucose utilization, but its site ofaction remains a challenging question.
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